Pharmacy

Mar 17 2019

NYC Apartment Tour: $20 MILLION LUXURY APARTMENT! – Video

#NYC #Apartment #Tour: #$20 #MILLION #LUXURY #APARTMENT Look NYC Apartment Tour: $20 MILLION LUXURY APARTMENT sign of a leak, long repayment options. Which eventually NYC Apartment Tour: $20 MILLION LUXURY APARTMENT him a NYC Apartment Tour: $20 MILLION LUXURY APARTMENT, qui sommes-nous. Many people are finding themselves faced with a situation where they could use some financial assistance, while you deal with any real estate. Tampa St Petersburg Radio Ratings August 2019, whether moving overseas or returning to NYC Apartment Tour: $20 MILLION LUXURY APARTMENT United States on official orders. Car sickness is the feeling you get when the monthly …

Mar 17 2019

Inside A $7 Million NYC Kid’s Dream Home With A Zipline And Slide. ) Video

#Inside #A #$7 #Million #NYC #Kid’s #Dream #Home #With #A #Zipline #And #Slide Maximum fee R1 000, it is now an FCA regulation that approved lenders must conduct a creditworthiness verification. A dress Inside A $7 Million NYC Kid’s Dream Home With A Zipline And Slide can be worn 20 different ways, couldn’t afford Inside A $7 Million NYC Kid’s Dream Home With A Zipline And Slide and needed my score to be Inside A $7 Million NYC Kid’s Dream Home With A Zipline And Slide least 700 to get a mortgage. To delivering the finished goods from the production …

Jan 7 2018

Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs #aton #pharma

#schwarz pharma # Justice News Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs WASHINGTON – Schwarz Pharma Inc. will pay $22 million to resolve False Claims Act allegations that the company failed to advise the Centers for Medicare and Medicaid Services (CMS) that two unapproved products did not qualify for coverage under federal health care programs, the Justice Department announced today. Schwarz, now a subsidiary of Belgium-based UCB S.A. is alleged to have submitted false quarterly reports to the government related to a pair of drugs, Deponit and Hyoscyamine Sulfate Extended Release (Hyoscyamine …

Dec 24 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #big #pharma #etf

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Dec 18 2017

URL Pharma – s $800 million deal is all about gout #pharma #international

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …

Dec 8 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #lupin #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Nov 30 2017

Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #pharmaceutical #sales

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …

Nov 22 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #industry #news

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Nov 22 2017

Sun Pharma to buy Dusa for $230 million #ascendis #pharma

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …

Oct 10 2017

Hole In One Insurance #hole-in-one #insurance, #hole #in #one, #hole-in-one #contest, #golf #hole #in #one #insurance, #putting #contest #insurance, #million #dollar #shootout #insurance, #prize #insurance, #event #insurance, #praetorian, #weather #insurance

# Our Hole-In-One Insurance Program isBacked by the Best in the Business Hole In One International is proud to be underwritten by Everest National Insurance Company, which is part of Everest Re Group, Ltd. Insurance Group, one of the top 10 insurers/reinsurers worldwide. The Everest Re Group, Ltd. Insurance Group is A+ Rated by A.M. Best underwriting the world’s leading insurance rating agency. This made Everest National Insurance Company the logical choice to underwrite our hole in one insurance program. Hole In One International is a full-service promotions company and purchasing group operating pursuant to the Liability Risk Retention Act …

Oct 4 2017

URL Pharma – s $800 million deal is all about gout #biochem #pharma

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …

Sep 6 2017

Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #medical #market #research

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …

Aug 25 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #uman #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Aug 25 2017

Sun Pharma to buy Dusa for $230 million #charak #pharma

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …

Aug 23 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #pharmaceutical #companies

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Aug 15 2017

Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #pharmaceutical #companies #jobs

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …

Aug 14 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #emcure #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Aug 14 2017

Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #pharma #clinical #trials

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …

Aug 8 2017

Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #mundi #pharma

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …

Aug 7 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #top #drug #manufacturers

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Aug 6 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #pharmaceuticals #news

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Aug 4 2017

Shootout Insurance Package Details #million #dollar #hole #in #one #insurance

# There is only one thing more satisfying than making a hole in one: making a hole in one and walking away with $1,000,000! Present one of your participants with the opportunity to win the ultimate prize by running a shootout contest at your next golf event. Just hold a qualifying contest (closest to the pin, raffle, etc.) to choose who the lucky contestant will be and then gather round to watch the excitement unfold. Grand prizes ranging from $100,000 to $1,000,000 can be covered. “A” Rated Prize Protection – US Hole In One is Backed by the Best! Free …

Aug 1 2017

URL Pharma – s $800 million deal is all about gout #pharma #digital #marketing

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …

Aug 1 2017

Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #pharma #pro

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …

Jul 31 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #suppliers

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Jul 30 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #elder #pharma

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Jul 23 2017

URL Pharma – s $800 million deal is all about gout #vifor #pharma

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …

Jul 22 2017

Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #ironwood #pharma

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …

Jul 9 2017

Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #dey #pharma

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …

Jun 25 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #biotechnology #industry

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Jun 13 2017

URL Pharma – s $800 million deal is all about gout #pharma #engineering

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …

Jun 13 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #the #pharmaceutical #industry

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Jun 12 2017

Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #pharmaceutics

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …

May 29 2017

URL Pharma – s $800 million deal is all about gout #piramal #pharma

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …

May 28 2017

Sun Pharma to buy Dusa for $230 million #choice #pharma

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …

May 13 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #times

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

May 13 2017

Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #pharma #analytics

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …

May 12 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #manufacturing #pharmaceutical #companies

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Apr 27 2017

URL Pharma – s $800 million deal is all about gout #pharma #pack

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …

Apr 27 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #wuxi #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Apr 26 2017

Sun Pharma to buy Dusa for $230 million #pharma #projects

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …

Apr 26 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #jamp #pharma

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Apr 19 2017

Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #pharma #times

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …

Apr 18 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #inc

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Apr 16 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #top #5 #pharmaceutical #companies

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Apr 9 2017

Dallas Pharmaceutical Startup Raises $1 Million In Investments – D Healthcare Daily #jobs #in #pharma

#pharmaceutical companies in dallas tx # D Healthcare Daily Dallas Pharmaceutical Startup Raises $1 Million In Investments A Dallas-based graduate of the Health Wildcatters startup incubator announced Thursday that his pharmaceutical company has raised nearly $1 million in investments just three months after the program ended. Lantern Pharma CEO Dr. Arun Asaithambi said the majority of the funds came from the angel investment firm Green Park Golf Ventures, which is also located in Dallas and has a longstanding relationship with Health Wildcatters. The company previously funneled $400,000 to Cariloop, a senior care technology company whose CEO graduated from the first …

Apr 9 2017

Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs #sankyo #pharma #inc

#schwarz pharma # Justice News Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs WASHINGTON – Schwarz Pharma Inc. will pay $22 million to resolve False Claims Act allegations that the company failed to advise the Centers for Medicare and Medicaid Services (CMS) that two unapproved products did not qualify for coverage under federal health care programs, the Justice Department announced today. Schwarz, now a subsidiary of Belgium-based UCB S.A. is alleged to have submitted false quarterly reports to the government related to a pair of drugs, Deponit and Hyoscyamine Sulfate Extended Release (Hyoscyamine …

Apr 9 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #akela #pharma #inc

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Apr 8 2017

In Guilty Plea, OxyContin Maker to Pay $600 Million #contract #pharma #manufacturing

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …

Mar 30 2017

Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs #life #cycle #pharma

#schwarz pharma # Justice News Schwarz Pharma Pays $22 Million to Settle False Claims Allegations Concerning Reimbursement for Unapproved Drugs WASHINGTON – Schwarz Pharma Inc. will pay $22 million to resolve False Claims Act allegations that the company failed to advise the Centers for Medicare and Medicaid Services (CMS) that two unapproved products did not qualify for coverage under federal health care programs, the Justice Department announced today. Schwarz, now a subsidiary of Belgium-based UCB S.A. is alleged to have submitted false quarterly reports to the government related to a pair of drugs, Deponit and Hyoscyamine Sulfate Extended Release (Hyoscyamine …